Tuesday 13 November 2018
Home      All news      Contact us      Philipino
Channel News Asia - 26 days ago

Merck, Pfizer combo treatment meets main goals of kidney cancer trial

Merck and Co said on Thursday a combination treatment of its cancer drug Keytruda and Pfizer Inc s Inlyta met the main goals of a late-stage study in patients with the most common form of kidney cancer.

Related news

Latest News
Hashtags:   

Merck

 | 

Pfizer

 | 

combo

 | 

treatment

 | 

meets

 | 

goals

 | 

kidney

 | 

cancer

 | 

trial

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources